Imaging Research in Alzheimer’s and Other Neurodegenerative Diseases Grant — Up to three awards funded each year totaling $200,000 each
The Alzheimer’s Association and the Foundation of the ASNR are partnering to offer a new, unique funding program: The Imaging Research in Alzheimer’s and Other Neurodegenerative Diseases Grant. The goal of this program is to support the development of new novel imaging tools, to advance imaging-based research and to provide funding for novel and innovative imaging data analysis as relates to Alzheimer’s and related dementia.
The Alzheimer’s Association’s mission is to end Alzheimer’s and all other dementia — by accelerating global research, driving risk reduction and early detection, and maximizing quality care and support. The Foundation of the American Society of Neuroradiology (ASNR) has a mission to promote education and research in the field of neuroradiology and the development of new ideas for clinical practice. The Association and the Foundation of the ASNR are partnering to offer this unique funding program to leverage their respective expertise and their communities.
Imaging is an important tool to better understand brain related changes in Alzheimer’s and other neurodegenerative diseases and to develop opportunities for early and accurate diagnosis. With ongoing and planned clinical studies to advance our understanding as well as to evaluate potential future treatments, it is important to incorporate imaging biomarkers into these trials as well as continuing to improve the diagnostic and prognostic power of these techniques.
The purpose of this partnership between the Alzheimer’s Association and the Foundation of the ASNR is to provide support for the advancement of the field of imaging of Alzheimer’s disease and other neurodegenerative diseases by providing support for early stage pilot projects that will advance research to support the development of new novel imaging tools, to advance imaging-based research and to provide funding for novel and innovative imaging data analysis.
This mechanism highly encourages investigators to include within an explicit plan for overcoming barriers to the enrollment of individuals from health disparity populations in their study.
The evaluation of causative factors including environmental and genetic factors contributing to disease development and progression, identifying potential new treatment strategies and information to improve care for people with dementia, and advancing our knowledge of risk reduction and disease prevention are long-term goals. The goal of this program is to translate research into strategies to increase our understanding of the pathogenesis of Alzheimer’s and other neurodegenerative diseases, and to help stratify populations and possible treatments.
Three awards, each having a maximum budget of $200,000 (including no more than 10% indirect costs), are available for one-year award.
Program Key Dates
For more information visit: alz.org/grants.
Click here to download complete application instructions via the RFA.
To inquire about eligibility, you can contact a member of the Alzheimer’s Association Grants staff at firstname.lastname@example.org.